In late June, the US Food and Drug Administration could approve the Epidiolex, a pharmaceuticalized form of CBD for several severe pediatric seizure disorders. According to data recently published in the New England Journal of Medicine, the drug can reduce seizures by more than 40%. If Epidiolex wins approval it would be the first time the agency approves a drug derived from the marijuana plant. (The FDA has approved synthetic THC to treat chemotherapy-related nausea.)
CBD has positive implications in a vast number of illnesses and has been shown to boost general health, hair and skin. Research isn’t conclusive here, although it is strong, and in the coming years, we are expecting to see more and more evidence. THC, on the other hand, can benefit other disorders but comes with drawbacks, such as the feelings of being high and possible induction of feelings of anxiety and paranoia and more.
The final advantage in the above list of a lower cost per milligram is one worth looking into further. As previously mentioned, because a full spectrum product is derived from a whole plant ex-tract it typically costs more (you the consumer are getting more than just CBD). Chase Terwilliger, CEO of CBDistillery, adds, "It is less expensive to manufacture isolate-based products com-pared to full-spectrum products. Rather than taking advantage of a larger margin, we decided to pass the savings along to the consumers." For those looking for a pure CBD product, you will al-so be delighted to find that CBD oil made from isolate is typically less expensive than a full-spectrum product. Which brings up a final point which is to do your research on the industry standard pricing for cost per milligram to ensure you are not paying an unnecessary premium.